Using cell-specific, Areg-deficient, and -overexpressing mice to determine the direct effects of Areg on lung alveolarization, vascularization, and pulmonary hypertension in experimental BPD models could inform us of Areg’s therapeutic potential for infants with BPD. Here, AREG is linked to pulmonary arterial hypertension.